Why the adult cannabis market could kill its medical counterpart

9/11/18–As more states continue to legalize recreational marijuana, speculation among industry pundits is that this could be the precursor to a major slowdown, if not death knell, for the medical marijuana industry. According to estimates by leading cannabis researchers ArcView Market Research in partnership with BDS Analytics, the latest revenue projections for the U.S. medical marijuana industry in 2018 is $4.3 billion versus $6.7 billion for adult use. Last year, medical racked up $5.9 billion while adult use snagged $2.6 billion. Read